EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Regional Differences and Coronary Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction

Mikael Erhardsson, Ulrika Ljung Faxén, Ashwin Venkateshvaran, Sara Svedlund, Antti Saraste, Maria Lagerström Fermer, Li-Ming Gan, Sanjiv J Shah, Jasper Tromp, Carolyn Sp Lam, Lars H Lund, Camilla Hage

ESC Heart Failure · 2023

DOI: 10.1002/ehf2.14569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2023. Verfasst von Mikael Erhardsson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cardiology Unit, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Heart Failure, Atrial Fibrillation, Coronary Artery Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, National Medical Research Council of Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In heart failure with preserved ejection fraction (HFpEF), regional heterogeneity of clinical phenotypes is increasingly recognized, with coronary microvascular dysfunction (CMD) potentially being a common shared feature. We sought to determine the regional differences in clinical characteristics and prevalence of CMD in HFpEF. Methods and results We analysed clinical characteristics and CMD in 202 patients with stable HFpEF (left ventricular ejection fraction ≥40%) in Finland, Singapore, Sweden, and United States in the multicentre PROMIS-HFpEF study. Patients with unrevascularized macrovascular coronary artery disease were excluded. CMD was assessed using Doppler echocardiography and defined as coronary flow reserve (adenosine-induced vs. resting flow) < 2.5. Patients from Singapore had the lowest body mass index yet highest prevalence of hypertension, dyslipidaemia, and diabetes; patients from Finland and Sweden were oldest, with the most atrial fibrillation, chronic kidney disease, and high smoking rates; and those from United States were youngest and most obese. The prevalence of CMD was 88% in Finland, 80% in Singapore, 77% in Sweden, and 59% in the United States; however, non-significant after adjustment for age, sex, N-terminal pro-brain natriuretic peptide, smoking, left atrial reservoir strain, and atrial fibrillation. Associations between CMD and clinical characteristics did not differ based on region (interaction analysis).

Conclusions

Despite regional differences in clinical characteristics, CMD was present in the majority of patients with HFpEF across different regions of the world with the lowest prevalence in the United States. This difference was explained by differences in patient characteristics. CMD could be a common therapeutic target across regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureAtrial FibrillationCoronary Artery DiseaseHumansUnited StatesStroke VolumeVentricular Function, Left

Stichwörter der Autor:innen

Coronary flow reserveCoronary microvascular dysfunctionHFpEFRegion

Autor:innen und Institutionen

  • Department of Medicine, Cardiology Unit, Karolinska Institutet, Stockholm, Sweden.
  • Karolinska University Hospital, Perioperative Medicine and Intensive Care, Stockholm, Sweden.
  • Department of Clinical Physiology, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
  • Heart Center, Turku University Hospital, University of Turku, Turku, Finland.
  • Early Clinical Development, IMED Biotech Unit, AstraZeneca Gothenburg, Sweden.
  • Ribocure Pharmaceuticals AB, Sweden, Suzhou Ribo Life Science Co. Ltd., China.

Förderung

  • NIH HHS
  • NHLBI NIH HHS
  • National Medical Research Council of Singapore
  • National Institutes of Health
  • Swedish Research Council
  • Swedish Heart Lung Foundation
  • National University of Singapore Start-up Grant
  • Ministry of Education

Zitieren

APA

Erhardsson, M., Ljung Faxén, U., Venkateshvaran, A., Svedlund, S., Saraste, A., Lagerström Fermer, M., Gan, L. M., Shah, S. J., Tromp, J., Sp Lam, C., Lund, L. H., & Hage, C. (2023). Regional Differences and Coronary Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. https://doi.org/10.1002/ehf2.14569

Vancouver

Erhardsson M, Ljung Faxén U, Venkateshvaran A, Svedlund S, Saraste A, Lagerström Fermer M, et al. Regional Differences and Coronary Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 2023. doi:10.1002/ehf2.14569

BibTeX
@article{Erhardsson2023,
  author = {Erhardsson, Mikael and Ljung Faxén, Ulrika and Venkateshvaran, Ashwin and Svedlund, Sara and Saraste, Antti and Lagerström Fermer, Maria and Gan, Li-Ming and Shah, Sanjiv J and Tromp, Jasper and Sp Lam, Carolyn and Lund, Lars H and Hage, Camilla},
  title = {Regional Differences and Coronary Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction},
  journal = {ESC Heart Failure},
  year = {2023},
  doi = {10.1002/ehf2.14569}
}
Kostenlos starten →